Kura Oncology Reports First Quarter 2017 Operational and Financial Results
May 15, 2017 20:07 pm UTC| Business
LA JOLLA, Calif., May 15, 2017 -- Kura Oncology, Inc., (NASDAQ:KURA) a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter 2017 financial...
Kura Oncology Reports First Quarter 2017 Operational and Financial Results
May 15, 2017 20:07 pm UTC| Business
LA JOLLA, Calif., May 15, 2017 -- Kura Oncology, Inc., (NASDAQ:KURA) a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter 2017 financial...
Kura Oncology Reports First Quarter 2017 Operational and Financial Results
May 15, 2017 20:07 pm UTC| Business
LA JOLLA, Calif., May 15, 2017 -- Kura Oncology, Inc., (NASDAQ:KURA) a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter 2017 financial...
May 15, 2017 20:07 pm UTC| Business
CHARLOTTESVILLE, Va., May 15, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
May 15, 2017 20:07 pm UTC| Business
CHARLOTTESVILLE, Va., May 15, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
May 15, 2017 20:07 pm UTC| Business
CHARLOTTESVILLE, Va., May 15, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
Five Prime Welcomes Garry Nicholson to Board of Directors
May 15, 2017 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 15, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...